Nasdaq Stockholm

Elicera Therapeutics AB

ISIN SE0015382080Filings at the FI

At a glance

Most recent filing on January 23, 2026 — an administrative filing by Magnus Essand on Jan 22, 2026.

We hold 24 visible filings, going back to June 6, 2021.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 24 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 24. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Magnus Essand Board member
280,000 sharesAdministrative
TradedJan 22, 2026FiledJan 23, 2026
Jamal El Mosleh Chief executive officer
176,500 SEKOpen-market sale
TradedMay 26, 2025FiledMay 27, 2025
Jamal El Mosleh Chief executive officer
1,496,250 SEKOpen-market sale
TradedMay 22, 2025FiledMay 27, 2025
Jamal El Mosleh Chief executive officer
131,800 SEKOpen-market sale
TradedMay 27, 2025FiledMay 27, 2025
Jamal El Mosleh Chief executive officer
667,275 SEKOpen-market sale
TradedMay 23, 2025FiledMay 27, 2025